Financial results for the period ended Jun 30, 2026
As filed · Anlon Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
What happened
FactAnlon Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. Phiroze Jeejeebhoy Towers,. Unaudited Financial Results (Standalone and Consolidated) of the Company as set.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
DelayedMostly, we are expecƟng by Q3 it will be normalized, because we are already geƫng the beƩer prices in our product, so it will be surely reflected in H1 result as well.
In Q2, we are already able to maintain that EBITDA margin which is the sustainable and which was in line with our earlier expectation somewhere around 25%.
Change
FactImplication
CapitSignal interpretationMargins
WithdrawnAs menƟoned earlier, we expect EBITDA margins to gradually normalize into 25% to 30% range as raw material cost stabilize and integraƟon benefit occurs.
While this transformaƟon has resulted in some near-term pressure on margins, we believe these iniƟaƟves meaningfully strengthen our long-term compeƟƟveness posiƟon, create a strong foundaƟon for sustainable growth.
Change
FactImplication
CapitSignal interpretationCapex
DelayedExpansion, yes, we are already doing the expansion for the around 130 CR of the new CAPEX.
we are expecƟng at least by Q1 of FY28 it should be if everything goes well because there are so many statutory approvals are also there.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- See, FY27 we are expecƟng as even last earnings call and last meeƟng also menƟoned that we are expecƟng somewh (management committed by FY27)
- We remain confident in our mid-term growth trajectory and conƟnue to work towards our target approximately 30% (management committed by FY27)
Evidence
- Financial Results for the quarter ended June 30, 2026(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%